The pancreatic cancer secretome activates the STAT3 signaling in pancreatic stellate cells to drive the secretion of muscle atrophy-inducing factors
Year: 2026
Type: article
Abstract: The pancreatic tumor microenvironment, a major component of pancreatic tumors, plays important roles in tumor progression, metastasis, and chemotherapy resistance. In patients with advanced pancreatic cancer, unintentional weight loss by muscle and/or adipose tissue atrophy, called cancer cachexia, is frequently observed. Although it is well established that cancer cells secrete muscle atrophy-inducing factors (MAIF), we investigated whether cancer cells also produce factors to facilitate the secretion of MAIF from microenvironmental cells. To test this possibility, pancreatic stellate cells were treated with conditioned medium from various pancreatic cancer cells (CCM). We revealed that CCM consistently activated STAT3 to secrete MAIF from stellate cells and that the secretion was not observed when CCM from brefeldin A (BFA)-treated cancer cells was added. These results suggest that conventionally secreted factors from cancer cells are responsible for the secretion of MAIF from stellate cells. On the other hand, BFA did not inhibit the secretion of MAIF from either pancreatic cancer cells or stimulated stellate cells. We therefore propose that not only conventionally, but also unconventionally secreted factors contribute to muscle atrophy.
Source: Scientific Reports
Institution: Beckman Research Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funder: Genentech
OpenAlex ID: W7155371463
